Molecular recognition in chemical and biological systems

E Persch, O Dumele, F Diederich - … Chemie International Edition, 2015 - Wiley Online Library
Abstract Structure‐based ligand design in medicinal chemistry and crop protection relies on
the identification and quantification of weak noncovalent interactions and understanding the …

Recent developments in drug discovery for leishmaniasis and human African trypanosomiasis

AS Nagle, S Khare, AB Kumar, F Supek… - Chemical …, 2014 - ACS Publications
Leishmaniasis is a parasitic disease that presents four main clinical syndromes: cutaneous
leishmaniasis (CL), mucocutaneous leishmaniasis (MCL), visceral leishmaniasis/kala azar …

Targeting trypanothione reductase, a key enzyme in the redox trypanosomatid metabolism, to develop new drugs against leishmaniasis and trypanosomiases

T Battista, G Colotti, A Ilari, A Fiorillo - Molecules, 2020 - mdpi.com
The protozoans Leishmania and Trypanosoma, belonging to the same Trypanosomatidae
family, are the causative agents of Leishmaniasis, Chagas disease, and human African …

Thioredoxin reductase and its inhibitors

F Saccoccia, F Angelucci, G Boumis… - Current Protein and …, 2014 - benthamdirect.com
Thioredoxin plays a crucial role in a wide number of physiological processes, which span
from reduction of nucleotides to deoxyriboucleotides to the detoxification from xenobiotics …

Targeting trypanothione metabolism in trypanosomatids

MC González-Montero, J Andrés-Rodríguez… - Molecules, 2024 - mdpi.com
Infectious diseases caused by trypanosomatids, including African trypanosomiasis (slee**
sickness), Chagas disease, and different forms of leishmaniasis, are Neglected Tropical …

Thiol redox biology of trypanosomatids and potential targets for chemotherapy

AE Leroux, RL Krauth-Siegel - Molecular and Biochemical Parasitology, 2016 - Elsevier
Trypanosomatids are the causative agents of African slee** sickness, Chagas' disease,
and the different forms of leishmaniasis. This family of protozoan parasite possesses a …

Identification of chalcone-based antileishmanial agents targeting trypanothione reductase

M Ortalli, A Ilari, G Colotti, I De Ionna, T Battista… - European journal of …, 2018 - Elsevier
All currently used first-line and second-line drugs for the treatment of leishmaniasis exhibit
several drawbacks including toxicity, high costs and route of administration. Furthermore …

Novel heteroaryl selenocyanates and diselenides as potent antileishmanial agents

Y Baquedano, V Alcolea, MÁ Toro… - Antimicrobial agents …, 2016 - journals.asm.org
ABSTRACT A series of new selenocyanates and diselenides bearing interesting bioactive
scaffolds (quinoline, quinoxaline, acridine, chromene, furane, isosazole, etc.) was …

Antileishmanial phytochemical phenolics: molecular docking to potential protein targets

IV Ogungbe, WR Erwin, WN Setzer - Journal of Molecular Graphics and …, 2014 - Elsevier
A molecular docking analysis has been carried out to examine potential Leishmania protein
targets of antiprotozoal plant-derived polyphenolic compounds. A total of 352 phenolic …

Polyamine-trypanothione pathway: an update

A Ilari, A Fiorillo, I Genovese… - Future Medicinal Chemistry, 2017 - Taylor & Francis
In trypanosomatids, polyamine and trypanothione pathways can be considered as a whole
unique metabolism, where most enzymes are essential for parasitic survival and infectivity …